The story of Viagra offers a complicated case study for investors eyeing pharma. While first sales were remarkable, recent patent lapse and the arrival of alternative versions have considerably impacted profitability. Moreover, mounting regulatory oversight and pressure to decrease medication prices pose continuous challenges. Thus, betting on f… Read More

The emergence of so-called "Elite Luxury Viagra" – often referring to exceptionally high doses ordered by rogue physicians – represents a unusually alarming trend. While standard dosages of the medication are intended for treating erectile dysfunction safely in most patients, these significantly elevated amounts pose a serious threat to cardiov… Read More